Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Rostislav A. Petrov"'
Autor:
Igor D. Zlotnikov, Alexander A. Ezhov, Rostislav A. Petrov, Maksim A. Vigovskiy, Olga A. Grigorieva, Natalya G. Belogurova, Elena V. Kudryashova
Publikováno v:
Pharmaceuticals, Vol 15, Iss 10, p 1172 (2022)
Bacterial infections and especially resistant strains of pathogens localized in macrophages and granulomas are intractable diseases that pose a threat to millions of people. In this paper, the theoretical and experimental foundations for solving this
Externí odkaz:
https://doaj.org/article/acf8ff5ff2d84ff4af5e7430b526ff08
Autor:
Stanislav A. Petrov, Aleksei E. Machulkin, Anastasia A. Uspenskaya, Nikolay Y. Zyk, Ekaterina A. Nimenko, Anastasia S. Garanina, Rostislav A. Petrov, Vladimir I. Polshakov, Yuri K. Grishin, Vitaly A. Roznyatovsky, Nikolay V. Zyk, Alexander G. Majouga, Elena K. Beloglazkina
Publikováno v:
Molecules, Vol 25, Iss 24, p 5784 (2020)
A strategy for stereoselective synthesis of molecular platform for targeted delivery of bimodal therapeutic or theranostic agents to the prostate-specific membrane antigen (PSMA) receptor was developed. The proposed platform contains a urea-based, PS
Externí odkaz:
https://doaj.org/article/ae00a4fa5629496f8c958afc95c1484f
Autor:
Vladimir A. Aladinskiy, Rostislav A Petrov, Yan A. Ivanenkov, Mark S. Veselov, Andrey A Ayginin, Alexey Kh Baimiev, Maria M Puchinina, Marina A Maximova, Anastasia V. Aladinskaya, Dmitry A. Skvortsov, Kseniya Yu Shvetc, Yulia V. Vakhitova, Alina A. Sofronova, Ilya A. Osterman, Andrey Kh Baimiev, Zulfiya R Zileeva, Katerina S Komarova, Dmitry S. Bezrukov, L. F. Zainullina, Victor A Terentiev, Bogdan A Zagribelnyy, Petr V. Sergiev, Alexey E. Machulkin, Renat S. Yamidanov, Olga A. Dontsova
Publikováno v:
Current Drug Discovery Technologies. 17:716-724
Background: The key issue in the development of novel antimicrobials is a rapid expansion of new bacterial strains resistant to current antibiotics. Indeed, World Health Organization has reported that bacteria commonly causing infections in hospitals
Publikováno v:
BIOTECHNOLOGY: STATE OF THE ART AND PERSPECTIVES. :158-160
The conjugates of paclitaxel and betulin with N-acetylgalactosamine were obtained, their affinity to the asialoglycoprotein receptor was evaluated via surface plasmon resonance spectroscopy technique. Thermodynamic dissociation constants (KD) were de
Autor:
Ya. A. Ivanenkov, Sergey V. Kovalev, Elena K. Beloglazkina, E. Yu. Yamansarov, Natalia L. Klyachko, Nikolai V. Zyk, Rostislav A Petrov, Dmitry A. Skvortsov, Sergei A Evteev, Anton V Lopukhov, Alexander G. Majouga
Publikováno v:
Russian Chemical Bulletin. 68:2331-2338
New ligands for targeted delivery to the liver based on glycoconjugated natural triterpenoids are proposed. Simple chemical transformations of starting lupane triterpenes led to betulin or betulinic acid conjugates with N-acetyl-d-galactosamine linke
Autor:
Rostislav A Petrov, Dmitry A. Skvortsov, Yulia V. Vakhitova, L. F. Zainullina, Andrey A Ayginin, Yan A. Ivanenkov, Marina A Maximova, Mark S. Veselov, Alina A. Sofronova, Petr V. Sergiev, G. I. Filkov, Alexey E. Machulkin, Katerina S Komarova, Anastasia V. Aladinskaya, Renat S. Yamidanov, Victor A Terentiev, Olga A. Dontsova, Alexander S. Malyshev, Alexey Kh Baimiev, Maria M Puchinina, Ilya A. Osterman, Dmitry S. Bezrukov, A. V. Chemeris, Zulfiya R Zileeva, Vladimir A. Aladinskiy
Publikováno v:
Combinatorial Chemistry & High Throughput Screening. 22:346-354
Aim and Objective:Antibiotic resistance is a serious constraint to the development of new effective antibacterials. Therefore, the discovery of the new antibacterials remains one of the main challenges in modern medicinal chemistry. This study was un
Autor:
Andrey Baymiev, Rostislav A Petrov, Svetlana Iu Iarovenko, Vladimir A. Aladinskiy, Renat S. Yamidanov, Alexey E. Machulkin, Yan A. Ivanenkov, Mark S. Veselov, Katerina S Komarova, Olga A. Dontsova, Alexander S. Malyshev, Anastasia V. Aladinskaya, Victor A Terentiev, Andrey A Ayginin, Alina A. Sofronova, Petr V. Sergiev, Dmitry A. Skvortsov, Sergey V. Sadovnikov, Dmitrii A. Lukianov, Ilya A. Osterman, Dmitry S. Bezrukov, R.T. Matniyazov
Publikováno v:
The Journal of Antibiotics. 72:827-833
The present report describes our efforts to identify new structural classes of compounds having promising antibacterial activity using previously published double-reporter system pDualrep2. This semi-automated high-throughput screening (HTS) platform
Autor:
Irina V. Saltykova, E. Yu. Yamansarov, E. I. Seleznev, Alexander G. Majouga, Sergey V. Kovalev, Elena K. Beloglazkina, Rostislav A Petrov, Dmitry O Shkil
Publikováno v:
Russian Chemical Bulletin. 68:855-861
Pentacyclic triterpene hydroxy acids were transformed into acetylene-containing derivatives: propargyl esters at the carboxy group and O-(hex-5-ynoyl) derivatives at the hydroxy group. The cytotoxicity of the synthesized compounds was examined agains
Autor:
Olga Y. Burenina, Dmitrii A Grishin, Yan A. Ivanenkov, Sergey V. Kovalev, Yury V. Timchenko, Alexander Vaneev, Svetlana Yu. Maklakova, Alexander G. Majouga, Natalia L. Klyachko, Rostislav A Petrov, Alexander Erofeev, Elena K. Beloglazkina, Emil Yu. Yamansarov, Roman Timoshenko, Petr V. Gorelkin, Elena V Lopatukhina, Evgenia E Ondar, Sergei A Evteev, Anton V Lopukhov, Sofiia R Mefedova
Publikováno v:
Molecular pharmaceutics. 18(1)
In this work, we have developed covalent and low molecular weight docetaxel delivery systems based on conjugation with N-acetyl-d-galactosamine and studied their properties related to hepatocellular carcinoma cells. The resulting glycoconjugates have
Autor:
Nikolay V. Zyk, Anastasia S. Garanina, Anastasia A. Uspenskaya, Yuri K. Grishin, Aleksei E. Machulkin, Vladimir I. Polshakov, Ekaterina A. Nimenko, Rostislav A Petrov, Nikolay Y. Zyk, Vitaly A. Roznyatovsky, Stanislav A. Petrov, Elena K. Beloglazkina, Alexander G. Majouga
Publikováno v:
Molecules, Vol 25, Iss 5784, p 5784 (2020)
Molecules
Volume 25
Issue 24
Molecules
Volume 25
Issue 24
A strategy for stereoselective synthesis of molecular platform for targeted delivery of bimodal therapeutic or theranostic agents to the prostate-specific membrane antigen (PSMA) receptor was developed. The proposed platform contains a urea-based, PS